Published in Pharmacoepidemiol Drug Saf on August 20, 2013
Comparative effectiveness research and its utility in In-clinic practice. Perspect Clin Res (2016) 0.83
Predictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data. Pharmacoepidemiol Drug Saf (2016) 0.77
Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol (2003) 11.24
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA (2001) 5.54
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA (2004) 5.25
Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ (2010) 5.19
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol (2006) 4.95
Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation (2006) 4.35
Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int (1996) 4.28
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ (2011) 2.40
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care (2007) 2.31
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM (2010) 2.27
Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol (2006) 2.07
Tradeoffs between accuracy measures for electronic health care data algorithms. J Clin Epidemiol (2011) 2.06
Insights into different results from different causal contrasts in the presence of effect-measure modification. Pharmacoepidemiol Drug Saf (2006) 1.99
Community-acquired acute renal failure. Am J Kidney Dis (1991) 1.92
Validity of administrative database coding for kidney disease: a systematic review. Am J Kidney Dis (2011) 1.73
CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.71
Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab (2002) 1.47
From here to JUPITER: identifying new patients for statin therapy using data from the 1999-2004 National Health and Nutrition Examination Survey. Circ Cardiovasc Qual Outcomes (2009) 1.34
Statin therapy for healthy men identified as "increased risk". JAMA (2012) 1.25
Incidence of severe acute renal failure in adults: results of a community based study. BMJ (1993) 1.24
Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats. Shock (2004) 1.23
Statin safety: an assessment using an administrative claims database. Am J Cardiol (2006) 1.22
Epidemiology of de novo acute renal failure in hospitalized African Americans: comparing community-acquired vs hospital-acquired disease. Arch Intern Med (2000) 1.20
Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting system. PLoS One (2011) 1.17
Muscle toxicity with statins. Pharmacoepidemiol Drug Saf (2010) 0.93
An assessment of statin safety by nephrologists. Am J Cardiol (2006) 0.93
Does simvastatin cause more myotoxicity compared with other statins? Ann Pharmacother (2009) 0.90
Multiple effects of HMG-CoA reductase inhibitors (statins) besides their lipid-lowering function. Kidney Int (2008) 0.82
Neuromuscular complications of statins. Phys Med Rehabil Clin N Am (2008) 0.80
Clinical Inquiries: Which drugs should post-MI patients routinely receive? J Fam Pract (2010) 0.78
High-potency statins are associated with increased hospitalisations with acute kidney injury. Evid Based Med (2013) 0.77
[Prevalence of undetected chronic kidney disease in dyslipidemic population treated in primary care. LIPICAP study]. Med Clin (Barc) (2008) 0.77
Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials. Curr Med Res Opin (2010) 0.77
High prevalence of undiagnosed kidney disease in those presenting with troponin positive acute coronary syndrome. Ren Fail (2012) 0.76
Variable selection for propensity score models. Am J Epidemiol (2006) 10.68
Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40
Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA (2008) 6.63
Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA (2012) 5.90
Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*. Crit Care Med (2014) 5.89
Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol (2006) 4.70
The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78
Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med (2006) 3.75
Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol (2012) 3.63
Altitude and all-cause mortality in incident dialysis patients. JAMA (2009) 3.62
Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med (2010) 3.57
Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33
Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol (2014) 3.18
Confounding control in healthcare database research: challenges and potential approaches. Med Care (2010) 3.01
Compliance with osteoporosis medications. Arch Intern Med (2005) 2.91
The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med (2013) 2.77
The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol (2011) 2.61
Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int (2009) 2.48
Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47
Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf (2008) 2.42
Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture. Ann Intern Med (2008) 2.40
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care (2007) 2.31
Evidence of sample use among new users of statins: implications for pharmacoepidemiology. Med Care (2014) 2.22
Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011. J Clin Endocrinol Metab (2014) 2.18
Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making (2006) 2.12
Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. Obstet Gynecol (2014) 2.11
Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol (2013) 2.06
Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events. Am J Cardiol (2003) 2.06
Does this patient with a pericardial effusion have cardiac tamponade? JAMA (2007) 2.04
Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review. Am J Kidney Dis (2008) 1.98
Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med (2012) 1.94
Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum (2006) 1.94
Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis (2011) 1.92
Measuring concurrent adherence to multiple related medications. Am J Manag Care (2009) 1.88
Premature ventricular complexes and the risk of incident stroke: the Atherosclerosis Risk In Communities (ARIC) Study. Stroke (2010) 1.82
Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. J Rheumatol (2007) 1.80
Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events. Am J Cardiol (2008) 1.78
Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension (2005) 1.77
Prescription opioid use among older adults with arthritis or low back pain. Arthritis Rheum (2006) 1.77
Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia. Clin Infect Dis (2005) 1.76
Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc (2011) 1.76
Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med (2011) 1.74
The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf (2011) 1.74
Case-control study supports extension of surveillance interval after colonoscopic polypectomy to at least 5 yr. Am J Gastroenterol (2007) 1.74
Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol (2009) 1.73
Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am J Epidemiol (2011) 1.72
Usefulness of ventricular premature complexes to predict coronary heart disease events and mortality (from the Atherosclerosis Risk In Communities cohort). Am J Cardiol (2006) 1.70
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum (2011) 1.68
Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs (2010) 1.67
Doubly robust estimation of causal effects. Am J Epidemiol (2011) 1.66
An information criterion for marginal structural models. Stat Med (2012) 1.65
Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med (2012) 1.64
Rituximab therapy for membranous nephropathy: a systematic review. Clin J Am Soc Nephrol (2009) 1.62
Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes (2013) 1.62
Different methods of balancing covariates leading to different effect estimates in the presence of effect modification. Am J Epidemiol (2009) 1.60
Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis. Arthritis Rheum (2006) 1.60
Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol (2006) 1.60
Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radiotherapy in the treatment of prostate cancer after radical prostatectomy. JAMA Intern Med (2013) 1.60
Patient, physician, and payment predictors of statin adherence. Med Care (2010) 1.59
A randomized, controlled trial of in-home drinking water intervention to reduce gastrointestinal illness. Am J Epidemiol (2005) 1.59
Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes. Am J Epidemiol (2008) 1.59
At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence. Health Aff (Millwood) (2010) 1.59
Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). JAMA Intern Med (2014) 1.58
Trends in use of surgical mesh for pelvic organ prolapse. Am J Obstet Gynecol (2012) 1.57
SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med (2007) 1.56
Improving care of patients at-risk for osteoporosis: a randomized controlled trial. J Gen Intern Med (2007) 1.56
The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf (2012) 1.56
Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol (2009) 1.56
Lipid testing among patients with diabetes who receive diabetes care from primary care physicians. Diabetes Care (2003) 1.52
Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med (2007) 1.50
Nonexperimental comparative effectiveness research using linked healthcare databases. Epidemiology (2011) 1.50
Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women. Int J Gen Med (2013) 1.49
Effect of electronic prescribing with formulary decision support on medication use and cost. Arch Intern Med (2008) 1.47
Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers. Med Care (2007) 1.47
The effect of cholesterol reduction with cholestyramine on renal function. Am J Kidney Dis (2005) 1.46
The role of the c-statistic in variable selection for propensity score models. Pharmacoepidemiol Drug Saf (2010) 1.45
Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid. J Bone Miner Res (2006) 1.43
Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med (2004) 1.42
Provider delay among patients with breast cancer in Germany: a population-based study. J Clin Oncol (2003) 1.41
Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis (2010) 1.40
Changing patterns of anemia management in US hemodialysis patients. Am J Med (2012) 1.39
Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. J Natl Cancer Inst (2012) 1.39
Identifying specific chemotherapeutic agents in Medicare data: a validation study. Med Care (2013) 1.36
More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med (2009) 1.31
Confounder summary scores when comparing the effects of multiple drug exposures. Pharmacoepidemiol Drug Saf (2010) 1.31